Skip to content

Price / sales at other companies

Baxter International logo
Baxter InternationalBAX
0.8×-0.9×
PTH
Pelthos Therapeutics Inc.PTHS
2.5×
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
1.7×+0.1×
BridgeBio Pharma logo
BridgeBio PharmaBBIO
24.8×-26.8×
RFL
Rafael Holdings, Inc.RFL
67.4×-18.4×
Opko Health logo
Opko HealthOPK
1.5×-0.1×

Other financials

Income statement

See full
Revenue$9.1M-22.0%
Gross profit$7.2M-30.0%
Operating income-$3.1M-342%
Net income-$3.3M-362%
EPS (diluted)-$0.22-375%

Balance sheet

See full
Cash & equivalents$11.0M-27.1%
Total debt$4.8M-7.1%
Total equity$21.6M-24.5%
Total assets$71.0M+1.5%

Cash flow

See full
Operating cash flow$387.0K-90.1%
CapEx--100%
Free cash flow$387.0K-89.9%

Valuation

See full
Market cap$97.09M+142%
Enterprise value$90.91M+212%

Profitability

See full
Gross margin82.9%-1.4pp
Operating margin-17.2%-125pp
Net margin-17.6%-103pp
FCF margin3.3%

Returns & leverage

See full
Return on equity-29.4%-86.3pp
Debt / equity0.2×0.0×
Current ratio-0.3×

Where this comes from

Calculated from Cumberland Pharmaceuticals’s reported figures.

Based on the most recent quarter.

The official record: Cumberland Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cumberland Pharmaceuticals's price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cumberland Pharmaceuticals's price / sales?
Cumberland Pharmaceuticals (CPIX) reported price / sales of 1.2× in Q1 2026.
How has Cumberland Pharmaceuticals's price / sales changed year-over-year?
Cumberland Pharmaceuticals's price / sales decreased by 19.4% year-over-year, from 1.4× to 1.2×.
What is the long-term trend for Cumberland Pharmaceuticals's price / sales?
Over 5 years (2020 to 2025), Cumberland Pharmaceuticals's price / sales has grown at a 2.5% compound annual growth rate (CAGR), from 1.2× to 1.3×.
What does price / sales mean?
Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.